Vivo Bio Tech Ltd

Vivo Bio Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vivo Bio Tech Ltd

₹ 38.6 1.26%
22 Nov - close price
vivobio.com BSE: 511509
About

Incorporated in 1987, Vivo Bio Tech Ltd is a supplier of SPF lab animals and is a breeder
& distributor of rodent models.

Key Points

Business Overview:[1]
Vivo Bio Tech is a full-service CRO offering
drug development & discovery services
to pharmaceutical & biotech companies.
The company provides both regulatory and
non-regulatory IND-enabling preclinical development services, screening and evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology,
the company provides design & development
of syngeneic/xenograft models for evaluation
of anti-cancer agents. Further, the company can customize In vivo DMPK studies to help profile drug candidates in both rodent and non-rodent animal models.

Website BSE
  • Market Cap ₹ 57.5 Cr.
  • Current Price ₹ 38.6
  • High / Low ₹ 56.0 / 30.8
  • Stock P/E 7.71
  • Book Value ₹ 40.1
  • Dividend Yield 0.00 %
  • ROCE 9.94 %
  • ROE 4.76 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.96 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -4.03% over past five years.
  • Company has a low return on equity of 5.05% over last 3 years.
  • Working capital days have increased from 206 days to 315 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
10.17 12.92 15.31 11.26 12.67 13.54 14.76 11.58 9.26 12.85 11.76 10.13 12.04
6.34 7.17 13.70 6.48 8.01 8.62 7.63 7.09 4.40 6.48 6.39 5.77 6.45
Operating Profit 3.83 5.75 1.61 4.78 4.66 4.92 7.13 4.49 4.86 6.37 5.37 4.36 5.59
OPM % 37.66% 44.50% 10.52% 42.45% 36.78% 36.34% 48.31% 38.77% 52.48% 49.57% 45.66% 43.04% 46.43%
0.03 0.00 -0.15 0.00 0.01 0.01 0.02 0.00 0.00 0.03 0.01 0.01 4.63
Interest 1.06 1.20 0.87 1.76 1.79 2.08 2.01 1.95 2.09 2.22 1.52 1.92 2.06
Depreciation 1.74 1.71 2.21 2.33 2.37 2.30 2.26 2.29 2.30 2.28 2.43 2.23 2.29
Profit before tax 1.06 2.84 -1.62 0.69 0.51 0.55 2.88 0.25 0.47 1.90 1.43 0.22 5.87
Tax % 74.53% 51.76% -58.02% 53.62% 78.43% 72.73% 28.47% 44.00% 29.79% 31.05% 48.95% 27.27% 10.73%
0.28 1.37 -0.69 0.32 0.12 0.15 2.06 0.14 0.33 1.32 0.74 0.17 5.23
EPS in Rs 0.20 0.96 -0.48 0.22 0.08 0.10 1.38 0.09 0.22 0.89 0.50 0.11 3.51
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
14.37 16.13 17.79 28.58 34.13 47.00 55.83 55.35 51.78 51.39 52.23 45.45 46.78
12.01 14.38 14.99 24.87 26.51 36.11 46.32 42.88 33.98 35.30 30.39 24.19 25.09
Operating Profit 2.36 1.75 2.80 3.71 7.62 10.89 9.51 12.47 17.80 16.09 21.84 21.26 21.69
OPM % 16.42% 10.85% 15.74% 12.98% 22.33% 23.17% 17.03% 22.53% 34.38% 31.31% 41.82% 46.78% 46.37%
0.76 0.88 0.95 0.89 0.40 0.13 0.01 0.05 0.08 0.10 0.04 0.04 4.68
Interest 0.78 0.39 0.51 0.47 1.29 2.37 2.64 3.10 3.67 4.27 7.99 7.95 7.72
Depreciation 1.57 1.56 3.05 3.35 3.90 4.64 5.06 5.17 5.59 7.45 9.27 9.29 9.23
Profit before tax 0.77 0.68 0.19 0.78 2.83 4.01 1.82 4.25 8.62 4.47 4.62 4.06 9.42
Tax % 49.35% 55.88% -142.11% -16.67% 11.66% 21.95% -23.08% -4.47% 34.11% 50.78% 42.64% 37.93%
0.39 0.29 0.46 0.91 2.50 3.12 2.25 4.44 5.68 2.20 2.65 2.53 7.46
EPS in Rs 0.42 0.31 0.49 0.97 2.67 3.17 1.82 3.45 4.23 1.54 1.78 1.70 5.01
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 11%
5 Years: -4%
3 Years: -4%
TTM: -5%
Compounded Profit Growth
10 Years: 24%
5 Years: 2%
3 Years: -24%
TTM: 178%
Stock Price CAGR
10 Years: %
5 Years: 4%
3 Years: -15%
1 Year: 15%
Return on Equity
10 Years: 10%
5 Years: 8%
3 Years: 5%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 9.35 9.35 9.35 9.35 9.35 9.85 12.35 12.89 13.42 14.26 14.90 14.90 14.90
Reserves -1.12 -0.83 -0.18 0.71 3.22 7.36 14.62 20.14 27.68 32.18 36.97 39.50 44.90
3.58 6.62 5.69 16.91 27.06 25.12 21.68 24.37 30.96 67.44 62.39 73.07 57.89
26.86 24.90 26.57 18.69 11.49 17.18 6.67 6.29 7.46 8.60 8.77 9.66 10.23
Total Liabilities 38.67 40.04 41.43 45.66 51.12 59.51 55.32 63.69 79.52 122.48 123.03 137.13 127.92
20.73 20.59 19.69 23.54 28.57 27.66 30.01 34.99 52.05 95.17 88.87 80.37 74.26
CWIP 0.00 0.00 0.07 0.04 2.96 3.94 0.07 0.15 0.32 0.87 1.90 9.21 11.30
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
17.94 19.45 21.67 22.08 19.59 27.91 25.24 28.55 27.15 26.44 32.26 47.55 42.36
Total Assets 38.67 40.04 41.43 45.66 51.12 59.51 55.32 63.69 79.52 122.48 123.03 137.13 127.92

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2.12 2.79 2.25 8.81 -5.66 11.11 -0.78 8.61 14.18 16.64 14.83 15.52
25.03 -1.42 -2.04 -7.20 -11.84 -4.72 -3.53 -10.23 -22.82 -51.11 -4.00 -7.95
-19.33 -0.44 -0.89 -0.32 6.83 -3.43 0.72 2.09 8.78 35.02 -11.18 -7.56
Net Cash Flow 7.82 0.93 -0.68 1.30 -10.67 2.96 -3.59 0.47 0.14 0.55 -0.34 0.01

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 102.36 97.30 88.43 48.79 82.03 91.48 54.98 69.11 51.39 85.37 86.52 94.76
Inventory Days 3.92 42.06 557.61 169.23 204.47 289.48 255.75 451.13 672.29 312.99 429.70 831.44
Days Payable 857.55 1,160.13 814.41 362.93 242.14 304.36 152.08 166.72 70.37 74.02 50.68 100.49
Cash Conversion Cycle -751.27 -1,020.76 -168.38 -144.91 44.36 76.61 158.65 353.52 653.31 324.35 465.53 825.71
Working Capital Days -456.44 -343.05 -291.55 -95.40 84.70 73.78 119.71 131.89 143.73 131.40 172.96 314.89
ROCE % 7.82% 7.94% 4.67% 5.98% 12.37% 15.57% 9.80% 13.86% 18.99% 9.40% 11.05% 9.94%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
39.84% 39.67% 42.16% 42.16% 42.16% 42.08% 42.08% 42.08% 42.08% 42.08% 42.08% 42.08%
60.16% 60.33% 57.84% 57.83% 57.84% 57.91% 57.92% 57.91% 57.92% 57.92% 57.92% 57.91%
No. of Shareholders 11,36412,45512,63213,03613,04813,06212,98913,00615,61518,97118,85219,545

Documents

Announcements

Annual reports

Credit ratings